Acquisition agreement for YM BioSciencesArrangement Agreement • January 28th, 2022
Contract Type FiledJanuary 28th, 2022Gilead Sciences and YM BioSciences have signed a definitive agreement under which Gilead will acquire YM for U.S.$2.95 per share in cash.